天津武清龙济医院男科医院天津市龙济医院泌尿外科医院治早泄,龙济医院看男科比较好,白庙客运站与天津武清区龙济男科近吗,龙济医院如何坐车,武清龙济医院主治哪象,在龙济医院男科做检查多少钱,泌尿系统感染症状到武清龙济医院

WASHINGTON, Nov. 9 (Xinhua) -- An international team of researchers funded by NASA and the National Science Foundation (NSF) will travel next month to one of Antarctica's most active, remote and harsh spots to determine how changes in the waters circulating under an active ice sheet are causing a glacier to accelerate and drain into the sea, the U.S. space agency announced Wednesday.The science expedition will be the most extensive ever deployed to Pine Island Glacier. It is the area of the ice-covered continent that concerns scientists most because of its potential to cause a rapid rise in sea level. Satellite measurements have shown this area is losing ice and surrounding glaciers are thinning, raising the possibility the ice could flow rapidly out to sea.The multidisciplinary group of 13 scientists, led by Robert Bindschadler, emeritus glaciologist of NASA's Goddard Space Flight Center, will depart from the McMurdo Station in Antarctica in mid- December and spend six weeks on the ice shelf. During their stay, they will use a combination of traditional tools and sophisticated new oceanographic instruments to measure the shape of the cavity underneath the ice shelf and determine how streams of warm ocean water enter it, move toward the very bottom of the glacier and melt its underbelly."The project aims to determine the underlying causes behind why Pine Island Glacier has begun to flow more rapidly and discharge more ice into the ocean," said Scott Borg, director of NSF's Division of Antarctic Sciences, the group that coordinates all U.S. research in Antarctica. "This could have a significant impact on global sea-level rise over the coming century."

MOSCOW, Nov. 25 (Xinhua) -- Russia's Proton-M carrier rocket was launched on Friday from the Baikonur space center in Kazakhstan with a Chinese communications satellite "AsiaSat-7", according to Russia's Federal Space Agency Roscosmos.Roscosmos' live broadcast on its official website showed that the Proton-M rocket atop the Briz-M upper stage was launched at 23: 10 Moscow time (1910 GMT). The separation of the satellite from the rocket was scheduled for 08:23 Moscow time (0423 GMT) on Saturday.The AsiaSat-7 which belongs to the Asia Satellite Telecommunications Company Limited (AsiaSat) located in Hong Kong, China, is a new generation satellite designed to replace AsiaSat 3S at the orbital location of 105.5 degrees East.The new satellite was expected to support a broad range of applications for the Asia-Pacific region, including television broadcast and VSAT (Very Small Aperture Terminal) networks.

ISLAMABAD, Oct. 15 (Xinhua) -- President Asif Ali Zardari said on Saturday that the government was committed to address the issues of special people including those afflicted with impaired vision and blindness and called for establishing highest standards for their care.In a message on the International White Cane Safety Day, the President asked the people and relevant government agencies to reflect on the problems of visually handicapped people.He asked them to come up with suggestions to achieve high standards in caring for the disabled as these exist in other civilized nations.The White Cane Safety Day was aimed at creating awareness about the problems and requirements of visually handicapped persons and to take practical steps to address these issues. Enditem

SINGAPORE, Dec. 18 (Xinhua) -- Two Chinese Navy ships called at Singapore's Changi port on Sunday on their way back to China from an escort mission in the Gulf of Aden and the waters off Somali.The destroyer Wuhan and the frigate Yulin were part of the ninth flotilla dispatched by China in July to guard commercial ships in the troubled waters against pirates.They are stopping over in Singapore for three days to replenish fuel, water and other logistic supplies, officials said.The task force will also have exchanges with the Singapore side on anti-pirate efforts, and visit Singapore's Information Fusion Center, which is aimed to promote collaboration and information sharing in maritime security.The Chinese sailors were received at the port in Changi Naval Base on Sunday morning by Colonel Tan Kai Cheong, commander of the 3rd Flotilla, Singapore Navy; Chinese Ambassador to Singapore Wei Wei and other Chinese diplomats, as well as representatives of Chinese companies and the Chinese community in Singapore.Guan Jianguo, commander of the Chinese flotilla, said the task force left the port of Zhanjiang in Guangdong province on July 2. The two Chinese naval warships made port calls in Kuwait and Oman for friendly visits before stopping over at Singapore.The Chinese flotilla escorted 280 commercial vessels, including both Chinese and foreign ships, during the five months of the escort mission in the Gulf of Aden and the waters off Somali.Sixteen of the escorted vessels were Singapore-registered.The Chinese task force and the anti-pirate flotilla dispatched by Singapore also organized exchange visits, and the commanders of the two flotillas also met for exchanges.The Chinese Navy ships will leave Singapore on Tuesday for their home country.

WASHINGTON, Nov. 11 (Xinhua) -- The U.S. Food and Drug Administration (FDA) on Friday approved HEMACORD, the first licensed hematopoietic progenitor cells-cord cell therapy.HEMACORD is indicated for use in hematopoietic stem cell transplantation procedures in patients with disorders affecting the blood forming system. For example, cord blood transplants have been used to treat patients with certain blood cancers and some inherited metabolic and immune system disorders."The use of cord blood hematopoietic progenitor cell therapy offers potentially life-saving treatment options for patients with these types of disorders," said Karen Midthun, director of FDA's Center for Biologics Evaluation and Research, in a statement.HEMACORD contains hematopoietic progenitor cells (HPCs) from human cord blood. Cord blood is one of three sources of HPCs used in transplants. The other two are bone marrow and peripheral blood. Once these HPCs are infused into patients, the cells migrate to the bone marrow where they divide and mature. When the mature cells move into the bloodstream they can partially or fully restore the number and function of many blood cells, including immune function.